JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients

BACKGROUND: The use of natalizumab in multiple sclerosis (MS) may favour JC virus reactivation; this phenomenon is usually asymptomatic but can, albeit rarely, evolve into frank progressive multifocal leucoencephalopathy (PML). METHODS: JCV-specific CD8+ T lymphocytes were evaluated by flow cytometr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mancuso, Roberta, Saresella, Marina, Hernis, Ambra, Marventano, Ivana, Ricci, Cristian, Agostini, Simone, Rovaris, Marco, Caputo, Domenico, Clerici, Mario
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3558446/
https://ncbi.nlm.nih.gov/pubmed/23232085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-248
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars